1. Safety and immunogenicity of a mRNA-based chikungunya vaccine in a phase 1 dose-ranging trial. (February 2019) Authors: Shaw, C.; Panther, L.; August, A.; Zaks, T.; Smolenov, I.; Bart, S.; Watson, M. Journal: International journal of infectious diseases Issue: Volume 79(2019)Supplement 1 Page Start: 17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗